Grand Rounds – Accelerating Investigator Inventions | Mass General Brigham Innovation Introduction and Strategy | Chris Coburn | Feb 21, 2023
Chris Coburn is Chief Innovation Officer, Mass General Brigham. A direct report to the system CEO, Coburn leads a team of 140 tasked with the commercial application of the unique capabilities of MGB’s 85,000 employees. His group is responsible for business development, investing, company creation, corporate alliances, commercial strategy setting, licensing, and innovation management. Selected team achievements include:
-Generating commercialization revenue exceeding $160 million annually. More than 300 companies have been spun-off from Mass General Brigham in the last decade.
-Managing a venture fund with nearly $500 million under management, one of the nation’s top performing academic venture investing groups as well as a digital innovation fund.
-High-value asset creation through corporate development, commercial market strategy setting, targeted translational funding, and large-scale IP protection.
-Strategic industry alliances in drug development, diagnostic systems, robotics, and AI.
-250 licenses per year and 4000 total collaborative agreements annually.
-Creating and growing the World Medical Innovation Forum as a leading national investment and innovation gathering. Now in partnership with Bank of America.
Prior to joining Mass General Brigham, Mr. Coburn was Executive Director of Cleveland Clinic Innovations where he established and grew the unit into one of the most recognized in the United States. During his tenure, Cleveland Clinic spun off 55 companies with nearly $700 million in equity investments. Cleveland Clinic had never previously launched a technology spin-off. His team also advanced Cleveland Clinic’s innovation leadership through multiple initiatives including the creation and management of the Medical Innovation Summit
Learn More: www.innovationmeshnetwork.org / innovation.massgeneralbrigham.org
Chief Innovation Officer: Chris Coburn
Grand Rounds Director: Marc Succi, MD